Table 1.
Clinical characteristics
| Total | Survivors | Non-survivors | P value | |
|---|---|---|---|---|
| N = 58 | N = 39 | N = 19 | ||
| Age (years) | 64 ± 10 | 65 ± 9 | 64 ± 11 | 0.618 |
| Male (n, %) | 31, 53% | 23, 59% | 8, 42% | 0.227 |
| BMI (kg/m²) | 25 ± 4 | 24 ± 4 | 26 ± 5 | 0.123 |
| Systolic blood pressure (mmHg) | 116 ± 20 | 118 ± 18 | 112 ± 24 | 0.352 |
| Diastolic blood pressure (mmHg) | 73 ± 13 | 74 ± 12 | 70 ± 13 | 0.305 |
| Heart rate (beats/min) | 79 ± 12 | 77 ± 11 | 84 ± 13 | 0.070 |
| NYHA functional class (n, %) | 0.019 | |||
| I | 2, 3% | 1, 3% | 1, 5% | |
| II | 26, 45% | 24, 61% | 2, 11% | |
| III | 24, 42% | 12, 31% | 12, 63% | |
| IV | 6, 10% | 2, 5% | 4, 21% | |
| NYHA class III–IV (n, %) | 30, 52% | 14, 36% | 16, 84% | 0.001 |
| eGFR (ml/min/1.73 m²) | 62 ± 30 | 64 ± 32 | 59 ± 26 | 0.526 |
| Albumin (g/dl) | 3.6 ± 0.8 | 3.6 ± 0.8 | 3.8 ± 0.6 | 0.169 |
| NT-proBNP (pg/ml) | 4543 (1615–13,505) | 2595 (955–8765) | 8062 (3533–16,451) | 0.181 |
BMI body mass index, NYHA New York Heart Association, eGFR estimated glomerular filtration rate, NT-proBNP N-terminal of the prohormone brain natriuretic peptide